| Year |
Citation |
Score |
| 2014 |
Jin Y, Bies R, Gastonguay MR, Wang Y, Stockbridge N, Gobburu J, Madabushi R. Predicted impact of various clinical practice strategies on cardiovascular risk for the treatment of hypertension: a clinical trial simulation study. Journal of Pharmacokinetics and Pharmacodynamics. 41: 693-704. PMID 25326066 DOI: 10.1007/S10928-014-9394-9 |
0.515 |
|
| 2012 |
Maitland ML, Wu K, Sharma MR, Jin Y, Kang SP, Stadler WM, Karrison TG, Ratain MJ, Bies RR. Estimation of renal cell carcinoma treatment effects from disease progression modeling. Clinical Pharmacology and Therapeutics. 93: 345-51. PMID 23443753 DOI: 10.1038/Clpt.2012.263 |
0.54 |
|
| 2012 |
Wessels AM, Jin Y, Pollock BG, Frank E, Lange AC, Vrijens B, Fagiolini A, Kupfer DJ, Rucci P, Kepple G, Anderton J, Buttenfield J, Bies RR. Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. International Clinical Psychopharmacology. 27: 291-7. PMID 22990142 DOI: 10.1097/Yic.0B013E3283597678 |
0.516 |
|
| 2012 |
Jin Y, Bies R, Gastonguay MR, Stockbridge N, Gobburu J, Madabushi R. Misclassification and discordance of measured blood pressure from patient's true blood pressure in current clinical practice: a clinical trial simulation case study. Journal of Pharmacokinetics and Pharmacodynamics. 39: 283-94. PMID 22569889 DOI: 10.1007/S10928-012-9250-8 |
0.535 |
|
| 2012 |
Sharma MR, Karrison TG, Jin Y, Bies RR, Maitland ML, Stadler WM, Ratain MJ. Resampling phase III data to assess phase II trial designs and endpoints. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2309-15. PMID 22287601 DOI: 10.1158/1078-0432.Ccr-11-1815 |
0.51 |
|
| 2010 |
Jin Y, Pollock BG, Coley K, Miller D, Marder SR, Florian J, Schneider L, Lieberman J, Kirshner M, Bies RR. Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking. Journal of Clinical Pharmacology. 50: 73-80. PMID 19843655 DOI: 10.1177/0091270009343694 |
0.527 |
|
| 2010 |
Jin Y, Pollock BG, Frank E, Cassano GB, Rucci P, Müller DJ, Kennedy JL, Forgione RN, Kirshner M, Kepple G, Fagiolini A, Kupfer DJ, Bies RR. Effect of age, weight, and CYP2C19 genotype on escitalopram exposure. Journal of Clinical Pharmacology. 50: 62-72. PMID 19841156 DOI: 10.1177/0091270009337946 |
0.548 |
|
| 2009 |
Jin Y, Pollock BG, Frank E, Florian J, Kirshner M, Fagiolini A, Kupfer DJ, Gastonguay MR, Kepple G, Feng Y, Bies RR. The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram. Journal of Clinical Pharmacology. 49: 176-84. PMID 19179296 DOI: 10.1177/0091270008327538 |
0.557 |
|
| Show low-probability matches. |